Research · EMNLP 2023
AutoTrial
Research on eligibility criteria design. AutoTrial helps design a trial's inclusion and exclusion criteria with a language model, drawing on similar earlier trials and giving the reasoning behind each output.
Who created AutoTrial?
AutoTrial was written by Keiji AI co-founders Zifeng Wang and Jimeng Sun, who is Keiji AI's CEO, with Cao Xiao.
What the paper found
- Tested on over 70,000 clinical trials.
- Won about 60% of human evaluations against GPT-3.5 baselines, with a much smaller parameter size.
How AutoTrial relates to TrialMind
It is research, not a TrialMind module or a separately sold product. Published methods like this one inform how TrialMind works; TrialMind is the product Keiji AI sells.
See how TrialMind handles this work: Biostatistics and trial design.
The paper
Zifeng Wang, Cao Xiao, Jimeng Sun. AutoTrial: Prompting Language Models for Clinical Trial Design. EMNLP, 2023.
Details checked against the published record on 2026-11-01.
Frequently asked questions
- Who created AutoTrial?
- AutoTrial was written by Keiji AI co-founders Zifeng Wang and Jimeng Sun, who is Keiji AI's CEO, with Cao Xiao.
- Is AutoTrial part of TrialMind?
- No. It is research, not a TrialMind module or a separately sold product. Published methods like this one inform how TrialMind works; TrialMind is the product Keiji AI sells.
- What did the AutoTrial paper find?
- Tested on over 70,000 clinical trials. Won about 60% of human evaluations against GPT-3.5 baselines, with a much smaller parameter size.
All publications
Every paper sits under its primary research area.